搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Conus californicus Conotoxin Cl10.1 CSB-YP515153DVU
CSB-EP515153DVU
CSB-BP515153DVU
CSB-MP515153DVU
CSB-EP515153DVU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Conus californicus Conotoxin Cl14.1b CSB-YP515154DVU
CSB-EP515154DVU
CSB-BP515154DVU
CSB-MP515154DVU
CSB-EP515154DVU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Conus californicus Conotoxin Cl14.8 CSB-YP515155DVU
CSB-EP515155DVU
CSB-BP515155DVU
CSB-MP515155DVU
CSB-EP515155DVU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Conus californicus Conotoxin Cl6.15 CSB-YP515156DVU
CSB-EP515156DVU
CSB-BP515156DVU
CSB-MP515156DVU
CSB-EP515156DVU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Conus californicus Conotoxin Cl6.6a CSB-YP515157DVU
CSB-EP515157DVU
CSB-BP515157DVU
CSB-MP515157DVU
CSB-EP515157DVU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Conus californicus Conotoxin Cl9.2 CSB-YP515158DVU
CSB-EP515158DVU
CSB-BP515158DVU
CSB-MP515158DVU
CSB-EP515158DVU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Iron-sulfur cluster repair protein DnrN (dnrN) CSB-YP515159NFZ
CSB-EP515159NFZ
CSB-BP515159NFZ
CSB-MP515159NFZ
CSB-EP515159NFZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas phage KPP10 Structural protein ORF4 CSB-YP515160FFY
CSB-EP515160FFY
CSB-BP515160FFY
CSB-MP515160FFY
CSB-EP515160FFY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermobispora bispora Mycothiol acetyltransferase (mshD) CSB-YP515161TMN
CSB-EP515161TMN
CSB-BP515161TMN
CSB-MP515161TMN
CSB-EP515161TMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Segniliparus rotundus L-cysteine:1D-myo-inositol 2-amino-2-deoxy-alpha-D-glucopyranoside ligase (mshC) CSB-YP515162SYE
CSB-EP515162SYE
CSB-BP515162SYE
CSB-MP515162SYE
CSB-EP515162SYE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nocardiopsis dassonvillei 1D-myo-inositol 2-acetamido-2-deoxy-alpha-D-glucopyranoside deacetylase (mshB) CSB-YP515163NHK
CSB-EP515163NHK
CSB-BP515163NHK
CSB-MP515163NHK
CSB-EP515163NHK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Truepera radiovictrix NAD (P)H-hydrate epimerase CSB-YP515164TQU
CSB-EP515164TQU
CSB-BP515164TQU
CSB-MP515164TQU
CSB-EP515164TQU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis lyrata subsp. lyrata CASP-like protein ARALYDRAFT_471923 (ARALYDRAFT_471923), partial CSB-YP515165DNZ1
CSB-EP515165DNZ1
CSB-BP515165DNZ1
CSB-MP515165DNZ1
CSB-EP515165DNZ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis lyrata subsp. lyrata Casparian strip membrane protein ARALYDRAFT_660474 (ARALYDRAFT_660474), partial CSB-YP515166DNZ1
CSB-EP515166DNZ1
CSB-BP515166DNZ1
CSB-MP515166DNZ1
CSB-EP515166DNZ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis lyrata subsp. lyrata CASP-like protein ARALYDRAFT_492822 (ARALYDRAFT_492822), partial CSB-YP515167DNZ1
CSB-EP515167DNZ1
CSB-BP515167DNZ1
CSB-MP515167DNZ1
CSB-EP515167DNZ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus salivarius Cell division protein DivIB (divIB), partial CSB-YP515168LNA
CSB-EP515168LNA
CSB-BP515168LNA
CSB-MP515168LNA
CSB-EP515168LNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halalkalicoccus jeotgali 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase (HacjB3_16066) CSB-YP515169HTF
CSB-EP515169HTF
CSB-BP515169HTF
CSB-MP515169HTF
CSB-EP515169HTF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactococcus lactis subsp. cremoris Riboflavin transporter RibU (ribU), partial CSB-YP515170LNE1
CSB-EP515170LNE1
CSB-BP515170LNE1
CSB-MP515170LNE1
CSB-EP515170LNE1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erwinia billingiae Multidrug resistance protein MdtG (mdtG), partial CSB-YP515171EMW
CSB-EP515171EMW
CSB-BP515171EMW
CSB-MP515171EMW
CSB-EP515171EMW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizophyllum commune Probable endonuclease LCL3 (LCL3), partial CSB-YP515172SXS1
CSB-EP515172SXS1
CSB-BP515172SXS1
CSB-MP515172SXS1
CSB-EP515172SXS1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>